↓ Skip to main content

Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled…

Overview of attention for article published in Journal of Diabetes, April 2024
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • One of the highest-scoring outputs from this source (#9 of 674)
  • High Attention Score compared to outputs of the same age (97th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news
9 news outlets

Readers on

mendeley
32 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Efficacy and safety of bexagliflozin compared with dapagliflozin as an adjunct to metformin in Chinese patients with type 2 diabetes mellitus: A 24‐week, randomized, double‐blind, active‐controlled, phase 3 trial
Published in
Journal of Diabetes, April 2024
DOI 10.1111/1753-0407.13526
Pubmed ID
Authors

Lingding Xie, Jie Han, Zhifeng Cheng, Dexue Liu, Jie Liu, Chunrong Xu, Wenli Sun, Qingju Li, Fang Bian, Wei Zhang, Jinyu Chen, Qian Zhu, Tara K. Thurber, J. Paul Lock, Bo Zhang

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 32 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 32 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 7 22%
Student > Bachelor 4 13%
Researcher 3 9%
Professor 2 6%
Student > Doctoral Student 1 3%
Other 3 9%
Unknown 12 38%
Readers by discipline Count As %
Medicine and Dentistry 10 31%
Unspecified 7 22%
Biochemistry, Genetics and Molecular Biology 2 6%
Computer Science 1 3%
Unknown 12 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 65. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#663,681
of 25,728,350 outputs
Outputs from Journal of Diabetes
#9
of 674 outputs
Outputs of similar age
#5,168
of 187,834 outputs
Outputs of similar age from Journal of Diabetes
#1
of 10 outputs
Altmetric has tracked 25,728,350 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 674 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 187,834 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 97% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them